Please assess the completion status of the following clinical trial:

Trial Title: Developing a Non-invasive Cardiac Functional Health Status Measurement Device

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Heart failure patient eligibility shall consist of the following:~Group 1a: 5 adult heart transplant patients~* Age ≥ 21 years old and \<74 years old~* Speaks and understands English~* Provides Informed Consent~Group 1b: 5 pediatric heart transplant patients~* Age ≥ 7 years old and \< 21 years old~* Speaks and understands English~* Provides Informed Consent~Group 2: 5 adult heart failure patients~* Age ≥ 21 years old and \<74 years old~* Speaks and understands English~* Provides Informed Consent~Group 3: 5 adult aged Fontan patients~* Age ≥ 21 years old and \<74 years old~* Speaks and understands English~* Provides Informed Consent~Group 4: 5 pediatric Fontan patients~* Age ≥ 7 years old and \< 21 years old~* Speaks and understands English~* Provides Informed Consent~Group 5: 5 pediatric patients limited to heart murmurs~* Age ≥ 7 years old and \< 21 years old~* Speaks and understands English~* Provides Informed Consent~Group 6: 5 normal adult patients~* Age ≥ 21 years old and \<74 years old~* Speaks and understands English~* Provides Informed Consent~Exclusion Criteria:~* • Unstable patients per judgment of the clinician prior to the start of the treatment~  * Patients unable to have blood pressure cuff measured on the upper arm~ * Inability to wear monitor on forehead~ * Patients will be excluded from the study if they have eaten, consume caffeinated beverages, or taken hypertensive medications within 2 hours of testing

- Gender: ALL
- Minimum Age: 7 Years
- Maximum Age: 74 Years
- Healthy Volunteers: t

Study Arms:
- CVInsight (TM) (Type: EXPERIMENTAL): Patient will be placed on a tilt table and pulse oximetry (Nonin Medical)and blood pressure will be measured at different table positions (different angles). A hemodynamic monitor called CVInsight(TM) will be used to monitor the pulse oximeter readings.

Based on this trial design, predict the completion outcome and termination type (if applicable).